Invitrogen™ Human CAZIP Synthetic Peptide

Ref.: BL-RE-176414Manufacturer ref.: PEP-1026 50 μg
€149.00 excl. VAT

CAZIP Synthetic Peptide, PEP-1026, from Invitrogen.

Gene ID (Enter)
23281
Species
Human
Purification method
Purified
Accession number
Q5JR59
Common name
Human CAZIP
Brand
Invitrogen

CAZIP Synthetic Peptide, PEP-1026, from Invitrogen.

CAZIP Synthetic Peptide, PEP-1026, from Invitrogen.

CAZIP, also known as TIP150, contains a leucine-zipper domain at the C-terminus and has at least three isoforms. CAZIP is expressed in heart during early cardiac development and in parts of the nervous system in later embryonic development. It is thought to bind microtubules and facilitate the end-binding protein 1 (EB1)-dependent loading of MCAK onto microtubules plus ends and orchestrates the dynamics at the plus end of microtubules. CAZIP may regulate the dynamics of microtubules at their growing distal tip.

Species

Species: Human.

Conservation

Storage: -20°C.

Formulation

Concentration: 200 μg/mL.

Regulatory status

Research only (RUO).

Packaging

Packaging: 50 μg.

Technical specifications

General
BrandInvitrogen
Supplier ref. (Fisher Scientific)15225029
Specifications
Gene ID (Enter)23281
SpeciesHuman
Purification methodPurified
Accession numberQ5JR59
Common nameHuman CAZIP
Concentration200 μg/mL
DescriptionSynthetic Peptide
FormatLiquid
FormulaPBS with 0.1% BSA and 0.02% sodium azide; pH 7.2
For use with (application)Blocking Assay, Control
Gene symbol(s)MTUS2
LyophilizedNo
Product typePeptide
Quantity50 μg
Regulatory statusRUO - research use only
Storage and shipping
Content and storage-20°C
Conservative0.02% sodium azide
Storage stampPBS

Origin and customs

Manufacturer ref.PEP-1026
Country of originUnited States
HS customs code3824 99 92 00
A question or a specific configuration?
Contact us for a quote.